Search results for "prostate"

showing 10 items of 621 documents

Consumption of the Whole-Grain Rye Bread and Progression of Prostate Cancer

2013

Abstract Whole-grain rye intake has been suggested to have anti-cancer effect, including changes in serum hormones and reduced prostate specific antigen (PSA) in animals and humans. In this study, we investigated the effect of high intake of whole-grain rye bread on prostate cancer progression as assessed by PSA concentration in men diagnosed with prostate cancer. Fifteen men with prostate cancer who did not receive prior therapy were randomised and given a daily supplement of 250 g refined wheat bread for two weeks and, afterwards, 250 g whole-grain rye bread for six weeks. Blood samples were taken from fasting men at baseline and after two and six weeks to measure the PSA and sex hormones…

2. Zero hungerRye breadConsumption (economics)MultidisciplinaryGeneral interestScienceQdigestive oral and skin physiology030232 urology & nephrologyrye breadfood and beveragesprostate cancermedicine.diseasesex hormonesWhole grains3. Good healthpsa03 medical and health sciencesProstate cancer0302 clinical medicine030220 oncology & carcinogenesismedicineFood scienceProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences
researchProduct

Exosome levels in human body fluids: A tumor marker by themselves?

2016

Despite considerable research efforts, the finding of reliable tumor biomarkers remains challenging and unresolved. In recent years a novel diagnostic biomedical tool with high potential has been identified in extracellular nanovesicles or exosomes. They are released by the majority of the cells and contain detailed molecular information on the cell of origin including tumor hallmarks. Exosomes can be isolated from easy accessible body fluids, and most importantly, they can provide several biomarkers, with different levels of specificity. Recent clinical evidence shows that the levels of exosomes released into body fluids may themselves represent a predictive/diagnostic of tumors, discrimin…

30030301 basic medicinePharmaceutical ScienceExosomesBioinformaticsExosome03 medical and health sciencesTumor BiomarkersProstate cancer0302 clinical medicineBody FluidNeoplasmsBiomarkers TumorHumansMedicineHigh potentialTumor markerBiomarkers; Body fluids; Early diagnosis; Exosomes; Extracellular vesicles; Follow-up; Prostate cancer; Biomarkers Tumor; Body Fluids; Humans; Neoplasm Recurrence Local; Neoplasms; Exosomes; 3003Prostate cancerSettore BIO/16 - Anatomia Umanabusiness.industryFollow-upHealthy subjectsCancerBiomarkerExtracellular vesiclesEarly diagnosiEarly diagnosismedicine.diseaseMicrovesiclesBody FluidsExosomeBody fluids030104 developmental biology030220 oncology & carcinogenesisNeoplasmExtracellular vesicleNeoplasm Recurrence LocalbusinessBiomarkersHumanEuropean Journal of Pharmaceutical Sciences
researchProduct

Development of polypeptide-based therapeutics for the treatment of castration resistant prostate cancer

2019

El cáncer de próstata (CaP) es el segundo cáncer más frecuente en los hombres. Los estudios han establecido el gen de fusión (T2E) compuesto por TMPRSS2 (serina proteasa dependiente de andrógenos) y ERG (factor de transcripción de la familia ETS) como un biomarcador potencial de CaP. La progresión en el CaP incluye tanto el receptor de andrógenos (AR) como el receptor del factor de crecimiento de insulina 1 (IGF-1R), y el tratamiento con un anticuerpo anti-IGF-1R (AVE1642) ha demostrado un gran potencial en el tratamiento de los pacientes con CaP T2E-positivos. Por ello, el desarrollo de terapias personalizadas basadas en polímeros terapéuticos puede favorecer el tratamiento de CaP para un …

:CIENCIAS DE LA VIDA::Biología humana [UNESCO]castration resistant prostate cancerpolymer antibody conjugatepolymer therapeuticconfocal microscopy:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]combination therapyabirateroneantibodiescell signalingtumor microenvironmentUNESCO::CIENCIAS DE LA VIDA::Biología molecular:CIENCIAS DE LA VIDA::Bioquímica [UNESCO]orthotopic mice modelflow cytometryUNESCO::CIENCIAS DE LA VIDA::BioquímicaUNESCO::CIENCIAS DE LA VIDA::Biología celularprostate cancernanomedicineUNESCO::QUÍMICA::Otras especialidades químicas:CIENCIAS DE LA VIDA::Biología celular [UNESCO]UNESCO::QUÍMICA::BioquímicaUNESCO::CIENCIAS DE LA VIDA::Biología humanacell trafficking:QUÍMICA::Otras especialidades químicas [UNESCO]:QUÍMICA::Bioquímica [UNESCO]
researchProduct

Relationship of Flow Rate with Symptoms, Quality of Life and Other Clinical Parameters in Patients with LUTS Suggestive of BPH

2001

The uroflowmetry data of a selected number of patients who took part to the QUIBUS study (366 traces selected after quality control by a central panel of reviewer) were evaluated for their relationships with age, prostate volume, and IPSS and ICS-BPH scores. Waiting time, flow time, voided volume, maximum flow rate (Q(max)) and average flow rate (Q(ave)) were the flow variables considered for analysis. Only measurements with total voided volume exceeding 100 ml were included.An increasing percentage of subjects with voided volume200 ml was observed over 65 years of age. Age did not affect neither Q(ave) nor Q(max )(p = n.s. at correlation analysis). In particular, Q(max)was15 ml/s in about …

AdultAged 80 and overMaleGynecologymedicine.medical_specialtybusiness.industryUrologyProstatic HyperplasiaMiddle AgedUrination Disordersmedicine.diseaseUrodynamicsQuality of lifeLower urinary tract symptomsInternal medicineEpidemiologyQuality of LifemedicineHumansProstate diseaseProstatismIn patientbusinessAgedEuropean Urology
researchProduct

Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine

2019

BackgroundProstate cancer incidence varies internationally largely attributable to differences in prostate-specific antigen (PSA) use. The aim of this study was to provide the most recent detailed international epidemiological comparison of prostate cancer incidence and mortality in six north-eastern European countries (Belarus, Estonia, Latvia, Lithuania, the Russian Federation and Ukraine).MethodsThe number of incident prostate cancer cases was obtained from the countries national cancer registries. Prostate cancer mortality and corresponding population data were extracted from the WHO Mortality Database. Age-specific and age-standardised incidence and mortality rates were calculated (Eur…

AdultBaltic StatesMaletrendsmedicine.medical_specialtyRepublic of BelarusEpidemiology030232 urology & nephrologyPrevalenceRussia03 medical and health sciencesProstate cancer0302 clinical medicineProstateSyöpätaudit - CancersEpidemiologymedicineHumans1506AgedOriginal ResearchAged 80 and overProstate cancerbusiness.industryIncidenceIncidence (epidemiology)Mortality rateProstatic NeoplasmsCancerGeneral MedicineMiddle Agedmedicine.diseasemortality1692Prostate-specific antigenmedicine.anatomical_structure030220 oncology & carcinogenesisincidencePSA uptakeUkrainebusinessDemography
researchProduct

Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: A contemporary series of 1800 interventions

2002

Abstract Objectives Contemporary series of open prostatectomies from Western countries are rare. Frequently, the analysis of the outcome of open prostatectomy refers to old experiences or to series from developing countries. Any comparison with transurethral resection of the prostate can be invalidated by complications of open surgery because of the lack of an adequate healthcare system and technology. Methods The Sicilian-Calabrian Society of Urology performed a retrospective study to assess the surgical management of benign prostatic hyperplasia in Sicily and Calabria in 1997 and 1998. A three-page questionnaire was sent to the 36 urologic units of these two Italian regions with more than…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrinary systemProstatic HyperplasiaPostoperative ComplicationsProstatemedicineHumansSicilyTransurethral resection of the prostateAgedRetrospective StudiesAged 80 and overProstatectomybusiness.industryProstatectomyTransurethral Resection of ProstateRetrospective cohort studyMiddle AgedUnited StatesSurgerymedicine.anatomical_structureTreatment OutcomeItalyConcomitantHealth Care SurveysComplicationbusinessOpen Prostatectomy
researchProduct

Intra‐ and interreader reproducibility of PI‐RADSv2: A multireader study

2018

Background The Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) has been in use since 2015; while interreader reproducibility has been studied, there has been a paucity of studies investigating the intrareader reproducibility of PI-RADSv2. Purpose To evaluate both intra- and interreader reproducibility of PI-RADSv2 in the assessment of intraprostatic lesions using multiparametric magnetic resonance imaging (mpMRI). Study type Retrospective. Population/subjects In all, 102 consecutive biopsy-naive patients who underwent prostate MRI and subsequent MR/transrectal ultrasonography (MR/TRUS)-guided biopsy. Field strength/sequences Prostate mpMRI at 3T using endorectal with phased…

AdultImage-Guided BiopsyMaleIntraclass correlationBiopsyPopulationContrast MediaArticle030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineHumansMedicineRadiology Nuclear Medicine and imagingMultiparametric Magnetic Resonance ImagingStage (cooking)educationMultiparametric Magnetic Resonance ImagingAgedRetrospective StudiesUltrasonographyAged 80 and overObserver VariationReproducibilityeducation.field_of_studymedicine.diagnostic_testbusiness.industryProstateProstatic NeoplasmsReproducibility of ResultsMiddle AgedProstate-Specific AntigenReference StandardsMagnetic Resonance ImagingPI-RADSDiffusion Magnetic Resonance ImagingTransrectal ultrasonographybusinessNuclear medicineAlgorithmsKappaJournal of Magnetic Resonance Imaging
researchProduct

Serum prolactin and tumors of the prostate: unchanged basal levels and lack of correlation to serum testosterone

1980

To investigate the possible role of circulatory levels of prolactin on the development of prostatic tumors, and to gain insight into the prolactin-androgen relationship, serum prolactin and testosterone were determined in 73 patients with newly diagnosed prostatic adenocarcinoma. Controls consisted of 32 patients with benign prostatic hyperplasia before treatment, 19 age-matched controls, and 21 young individuals. Hormones were measured under standardized conditions by highly specific and sensitive radioimmunoassays. There was no difference in prolactin in the elderly men regardless of prostate pathology, but a significant increment was found in young controls. Individual prolactin values d…

AdultMaleAgingendocrine systemmedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismProstatic HyperplasiaStimulationAdenocarcinomaProstate cancerEndocrinologyProstateInternal medicineHumansMedicineTestosteroneAgedbusiness.industryProstatic NeoplasmsRadioimmunoassayMiddle AgedHyperplasiamedicine.diseaseAndrogenProlactinProlactinEndocrinologymedicine.anatomical_structurebusinesshormones hormone substitutes and hormone antagonistsHormoneJournal of Endocrinological Investigation
researchProduct

Biodosimetry Based on γ-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated Radiotherapy

2015

The aim of this current study was to quantitatively describe radiation-induced DNA damage and its distribution in leukocytes of cancer patients after fractionated partial- or total-body radiotherapy. Specifically, the impact of exposed anatomic region and administered dose was investigated in breast and prostate cancer patients receiving partial-body radiotherapy. DNA double-strand breaks (DSBs) were quantified by γ-H2AX immunostaining. The frequency of unstable chromosomal aberrations in stimulated lymphocytes was also determined and compared with the frequency of DNA DSBs in the same samples. The frequency of radiation-induced DNA damage was converted into dose, using ex vivo generated ca…

AdultMaleDNA damagemedicine.medical_treatmentBiophysicsBiologyRadiation ToleranceHistonesYoung AdultProstate cancerBiodosimetryNeoplasmsmedicineHumansRadiology Nuclear Medicine and imagingLymphocytesRadiation InjuriesRadiometryAgedAged 80 and overChromosome AberrationsRadiationbusiness.industryRadiotherapy Planning Computer-AssistedCancerDose-Response Relationship RadiationMiddle AgedTotal body irradiationmedicine.diseaseRadiation therapyCalibrationCytogenetic AnalysisFemaleDose Fractionation RadiationNuclear medicinebusinessWhole-Body IrradiationImmunostainingEx vivoDNA DamageRadiation Research
researchProduct

External Validation of Nomogram Predicting the Probability of Specimen-Confined Disease (pT2-3a, R0N0) in Patients Undergoing Radical Prostatectomy a…

2014

Introduction: Before radical prostatectomy (RP), a nomogram [Briganti et al., Eur Urol 2012;61:584-592] permits to measure the probability of specimen-confined (SC) disease (pT2-pT3a, node negative with negative margins) in high-risk prostate cancer (PCa). The aim of our study was to perform an external validation of this nomogram. Materials and Methods: Between 2007 and 2011, 623 patients with high-risk PCa (prostate-specific antigen (PSA) >20 ng/ml and/or biopsy Gleason score ≥8 and/or clinical stage T3) underwent RP and pelvic lymph node dissection at tertiary referral centers. Multivariable logistic regression models predicting the presence of SC disease were built in; we then used the …

AdultMaleHigh-risk prostate cancermedicine.medical_specialtyUrologymedicine.medical_treatmentHigh-risk prostate cancer; Nomogram; Radical prostatectomyUrologyReproducibility of ResultRadical prostatectomy; High-risk prostate cancer; Nomogramurologic and male genital diseasesSensitivity and SpecificityRegression AnalysiNomogramCohort StudiesRisk FactorsmedicineHumansIn patientMultivariate AnalysiLymph nodeAgedProbabilityAged 80 and overProstatectomyProstatectomybusiness.industryRisk FactorExternal validationProstatic NeoplasmsReproducibility of ResultsMiddle AgedProstate-Specific AntigenNomogramRadical prostatectomyNomogramsProstate-specific antigenDissectionmedicine.anatomical_structureROC CurveProstatic NeoplasmCalibrationMultivariate AnalysisLymph Node ExcisionRegression AnalysisCohort StudiebusinessHuman
researchProduct